Gene · 3433
Papers3,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,694
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mfn2 is responsible for inhibition of the RIG-I/IRF7 pathway and activation of NLRP3 inflammasome in Seneca Valley virus-infected PK-15 cells to promote viral replication. | Front Immunol | 2022 | 35958608 | PubTator, text mining | PubMed |
| Short Arrestin-3-Derived Peptides Activate JNK3 in Cells. | Int J Mol Sci | 2022 | 35955810 | PubTator, text mining | PubMed |
| The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved. | Cells | 2022 | 35954309 | PubTator, text mining | PubMed |
| Viral-mediated activation and inhibition of programmed cell death. | PLoS Pathog | 2022 | 35951530 | PubTator, text mining | PubMed |
| Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection. | Adv Appl Bioinform Chem | 2022 | 35941993 | PubTator, text mining | PubMed |
| RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS. | Genes Immun | 2022 | 35941292 | PubTator, text mining | PubMed |
| Research progress on the proteins involved in African swine fever virus infection and replication. | Front Immunol | 2022 | 35935977 | PubTator, text mining | PubMed |
| Advances in understanding interferon-mediated immune responses to enteric viruses in intestinal organoids. | Front Immunol | 2022 | 35935957 | PubTator, text mining | PubMed |
| mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant. | Commun Biol | 2022 | 35933439 | PubTator, text mining | PubMed |
| DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. | Immunity | 2022 | 35931086 | PubTator, text mining | PubMed |
| Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases. | Front Immunol | 2022 | 35928814 | PubTator, text mining | PubMed |
| Cytokine Activation Reveals Tissue-Imprinted Gene Profiles of Mesenchymal Stromal Cells. | Front Immunol | 2022 | 35924240 | PubTator, text mining | PubMed |
| Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach. | 3 Biotech | 2022 | 35923684 | PubTator, text mining | PubMed |
| Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis. | Mol Med | 2022 | 35922752 | PubTator, text mining | PubMed |
| African swine fever control and prevention: an update on vaccine development. | Emerg Microbes Infect | 2022 | 35912875 | PubTator, text mining | PubMed |
| 2B and 3C Proteins of Senecavirus A Antagonize the Antiviral Activity of DDX21 via the Caspase-Dependent Degradation of DDX21. | Front Immunol | 2022 | 35911774 | PubTator, text mining | PubMed |
| Suppression of influenza virus infection by rhinovirus interference - at the population, individual and cellular levels. | Curr Res Microb Sci | 2022 | 35909608 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage. | Front Immunol | 2022 | 35903092 | PubTator, text mining | PubMed |
| The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis. | Front Cell Dev Biol | 2022 | 35898403 | PubTator, text mining | PubMed |
| The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. | Int J Mol Sci | 2022 | 35897826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3433/papers?page=43